CONVERT: An international randomized trial of concurrent chemoradiotherapy (cCTRT) comparing twice-daily (BD) and once-daily (OD) radiotherapy schedules in patients with limited stage small cell lung cancer (LS-SCLC) and good performance status (PS) - Faivre-Finn, C; Snee, M; Ashcroft, L (J Clin Oncol, 2016)
(suppl; abstr 8504)